This grant is for supporting the 12 Regional Biocontainment Laboratories (RBLs) previously established with NIAID assistance. Its primary purpose is to enable these RBLs to develop and maintain essential resources, trained staff, and facilities crucial for addressing biodefense agents, emerging infectious diseases, and pandemic preparedness, aligning with NIAID priorities. The funding provides operational support for facility maintenance, general operations, and Biosafety Level 3 (BSL-3) practices, ensuring personnel safety and proficiency. An optional component allows RBLs to offer specialized services vital for BSL-3 activities. Ultimately, these RBLs will function as regional hubs, facilitating pre-clinical and laboratory research and testing on hazardous biological agents to advance NIAID’s critical biodefense and public health research efforts.
Opportunity ID: 344925
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-22-075 |
| Funding Opportunity Title: | Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 15, 2022 |
| Last Updated Date: | Dec 15, 2022 |
| Original Closing Date for Applications: | Feb 22, 2023 |
| Current Closing Date for Applications: | Feb 22, 2023 |
| Archive Date: | Mar 30, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Funding Opportunity Announcement for additional details on eligibility |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The goal of this Funding Opportunity Announcement (FOA) is to provide support to the 12 Regional Biocontainment Laboratories (RBLs) previously constructed with NIAID support to enable them to develop and maintain resources, staff, and facilities necessary to address biodefense agents, emerging infectious diseases, and pandemic preparedness in line with NIAID priorities. Operations support is provided for facility maintenance and operations, as well as Biosafety Level 3 (BSL-3) practices support for personnel working in and around BSL-3 space and associated building systems. An optional component would allow the RBLs to provide specialized services essential to support BSL3 activities. The RBLs will serve as regional resources for efforts in conducting pre-clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs biodefense, emerging infectious diseases, and pandemic preparedness research efforts. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-075.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 344925 Full Announcement-RFA-AI-22-075 -> RFA-AI-22-075-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278933 | Jan 22, 2023 | Feb 22, 2023 | View |
Package 1
Mandatory forms
344925 RR_SF424_5_0-5.0.pdf
344925 PHS398_CoverPageSupplement_5_0-5.0.pdf
344925 RR_OtherProjectInfo_1_4-1.4.pdf
344925 PerformanceSite_4_0-4.0.pdf
344925 RR_KeyPersonExpanded_4_0-4.0.pdf
344925 PHS398_ResearchPlan_5_0-5.0.pdf
344925 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344925 PHS_Additional_IndirectCosts_2_0-2.0.pdf
344925 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
